Hiligsmann, Mickaël ; Université de Liège - ULiège > Département des sciences de la santé publique > Département des sciences de la santé publique
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
French
Title :
Un monde médical et économique en pleine évolution : maladies complexes et intérêt de l’évaluation économique des technologies de santé
Publication date :
2012
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Banta D, Jonsson E. - History of HTA : introduction. Int J Technol Assess Health Care, 2009, 25, 1-6.
INAHTA. - International Network of Agencies for HTA. http://inahta. episerverhotell.net/HTA/.
Cleemput I, van Wilder P, Huybrechts M, et al. - Belgian methodological guidelines for pharmacoeconomic evaluations : toward standardization of drug reimbursement requests. Value Health, 2009, 12, 441-449.
Taylor RS, Drummond MF, Salkeld G, et al. - Inclusion of cost effectiveness in licensing requirements of new drugs : the fourth hurdle. Bmj, 2004, 329, 972-975. (Pubitemid 39422918)
Briggs A, Claxton K, Sculpher M. - Decision modelling for health economic evaluation, 2nd edition. NewYork. Oxford University Press. 2007.
Drummond M, Sculpher M, Torrance G, et al. - Methods for the economic evaluation of health care programmes, 3th edition. New-York. Oxford University Press. 2007.
Cleemput I, Neyt M, Thiry N, et al. - Valeurs seuils pour le rapport coÛt-efficacité en soins de santé. Health Technology Assessment (HTA). Bruxelles. Centre fédéral d'expertise des soins de santé (KCE);2008. KCE Reports, 100B (D/2008/10.273/95), 2008.
Raftery J. - NICE. faster access to modern treatments? Analysis of guidance on health technologies. Bmj, 2001, 323, 1300-1303.
Soto J. - Health economic evaluations using decision analytic modeling. Principles and practices - utilization of a checklist to their development and appraisal. Int J Technol Assess Health Care, 2002, 18, 94-111. (Pubitemid 34408532)
Sheldon TA. - Problems of using modelling in the economic evaluation of health care. Health Econ, 1996, 5, 1-11.
Decision analytic modelling in the economic evaluation of health technologies. A consensus statement. Consensus Conference on Guidelines on Economic Modelling in Health Technology Assessment. Pharmacoeconomics, 2000, 17, 443-444.
Brennan A, Akehurst R. - Modelling in health economic evaluation. What is its place? What is its value? Pharmacoeconomics, 2000, 17, 445-459. (Pubitemid 30398804)
O'Brien B. - Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials? Med Care, 1996, 34, DS99-108.
Hoffmann C, Graf von der Schulenburg JM. - The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. Health Policy, 2000, 52, 179-192. (Pubitemid 30336269)
Bormans V, Van Wilder P. - Effectiveness, efficiency and budget impact affect the Belgian drug reimbursment decision. ISPOR 14th Annual European Congress Madrid. Spain. November 2011.
Annemans L. - L'économie de la santé pour les non économistes. Une introduction aux notions, aux méthodes et aux écueils de l'eváluation économique en santé. Gent. Academia Press, 2008.
Drummond M, Barbieri M, Cook J, et al. - Transferability of economic evaluations across juridictions : ISPOR good research practices task force report. Value Health, 2009, 12, 409-418.
